Since the inception of this PPG 17 years ago, the goal of Core A has remained constant: to maximize the scientific progress and productivity of each project by providing responsive and effective centralized support services. The services provided fall under the following categories: Administrative, Statistical, and Research Personnel for Clinical Studies. The objectives of Core A are to provide all PPG projects and Core B with: 1) the leadership, oversight, and administrative support essential to maximize program performance; 2) the statistical support required to plan, conduct, and analyze data for all PPG studies;and 3) the personnel support necessary to successfully conduct and complete all PPG clinical studies. Core A achieves these objectives by coordinating the use of resources, services, and personnel. We foresee and have prepared for new scientific/medical challenges and opportunities in our renewal as we: 1) expand our focus to include a new but related research interest - neonatal thrombocytopenia - to provide crifically needed informafion about this common problem responsible for significant morbidity and health care costs; 2) add two new performance sites - Children's Hospital Boston, and the University of Minnesota Children's Hospital - to draw on the expertise of physician-scientists performing research at these sites that is directly related to our PPG;and 3) add four new investigators and seven new consultants, with most located at the new sites and others at Emory University, the University of Cincinnati and the State University of New York at Buffalo. The logistical challenges presented by the increase in complexity associated with our renewal are offset byenhanced opportunities for outstanding team-driven scientific progress and productivity. In the section "/. Overview of Core A, we list the new and continuing program investigators and consultants;in section "//. Detailed description of Core A components," we describe in detail the multifaceted structural approach that we have developed over the past 18 months to coordinate the activities and facilitate information exchange among investigators and staff dispersed across mulfiple performance sites.

Public Health Relevance

Anemia and thrombocytopenia are the two most common life-threatening and costly hematological problems encountered in NICUs throughout the US. Indeed, from a public-health standpoint, severe, transfusion-dependent anemia and thrombocytopenia remain expensive health-care problems with significant and costly short- and long-term adverse outcomes and health burdens. In supporting all 4 projects of this PPG, Core A contributes significantly to the development of the definitive, scientific evidence-based guidelines that will be needed for improved management of these two conditions.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
2P01HL046925-16A1
Application #
8324328
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
16
Fiscal Year
2012
Total Cost
$322,028
Indirect Cost
$101,429
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Peters, Anna L; Beuger, Boukje; Mock, Donald M et al. (2016) Clearance of stored red blood cells is not increased compared with fresh red blood cells in a human endotoxemia model. Transfusion 56:1362-9
Bastian, Thomas W; Duck, Kari A; Michalopoulos, George C et al. (2016) Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain-barrier and impairs iron-dependent hippocampal neuron dendrite development. J Thromb Haemost :
Witmer, Jordan R; Wetherell, Bailey J; Wagner, Brett A et al. (2016) Direct spectrophotometric measurement of supra-physiological levels of ascorbate in plasma. Redox Biol 8:298-304
Zamora, Tara G; Guiang 3rd, Sixto F; Widness, John A et al. (2016) Iron is prioritized to red blood cells over the brain in phlebotomized anemic newborn lambs. Pediatr Res 79:922-8
Patel, Ravi M; Knezevic, Andrea; Shenvi, Neeta et al. (2016) Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis in Very Low-Birth-Weight Infants. JAMA 315:889-97
Patel, Ravi Mangal; Meyer, Erin K; Widness, John A (2016) Research Opportunities to Improve Neonatal Red Blood Cell Transfusion. Transfus Med Rev 30:165-73
Ekhaguere, Osayame A; Morriss Jr, Frank H; Bell, Edward F et al. (2016) Predictive factors and practice trends in red blood cell transfusions for very-low-birth-weight infants. Pediatr Res 79:736-41
Weisenhorn, Erin M M; van T Erve, Thomas J; Riley, Nicholas M et al. (2016) Multi-omics Evidence for Inheritance of Energy Pathways in Red Blood Cells. Mol Cell Proteomics 15:3614-3623
Kuruvilla, Denison J; Widness, John A; Nalbant, Demet et al. (2016) A Mass Balance-Based Semiparametric Approach to Evaluate Neonatal Erythropoiesis. AAPS J 18:187-95
Al-Ghananim, Raeda T; Nalbant, Demet; Schmidt, Robert L et al. (2016) Reticulocyte Hemoglobin Content During the First Month of Life in Critically Ill Very Low Birth Weight Neonates Differs From Term Infants, Children, and Adults. J Clin Lab Anal 30:326-34

Showing the most recent 10 out of 179 publications